| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 43.758 | 78.491 | 76.512 | 75.178 | 81.869 | 99.790 | 112.742 |
| Total Income - EUR | - | - | - | 43.758 | 78.492 | 76.513 | 77.706 | 81.870 | 99.791 | 112.744 |
| Total Expenses - EUR | - | - | - | 35.488 | 51.105 | 56.968 | 44.015 | 37.482 | 54.518 | 62.807 |
| Gross Profit/Loss - EUR | - | - | - | 8.270 | 27.387 | 19.545 | 33.691 | 44.388 | 45.273 | 49.936 |
| Net Profit/Loss - EUR | - | - | - | 7.833 | 26.604 | 18.832 | 33.030 | 43.693 | 44.275 | 46.622 |
| Employees | - | - | - | 2 | 3 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - House Med Hodor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 47 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 10.097 | 36.633 | 53.874 | 85.761 | 129.654 | 177.030 | 85.515 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 976 |
| Receivables | - | - | - | 5.037 | 7.316 | 6.042 | 6.270 | 6.785 | 172.371 | 41.415 |
| Cash | - | - | - | 5.059 | 29.316 | 47.833 | 79.491 | 122.869 | 4.659 | 43.124 |
| Shareholders Funds | - | - | - | 7.876 | 34.328 | 52.509 | 84.374 | 128.328 | 172.214 | 47.731 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.301 | 2.337 | 1.397 | 1.417 | 1.356 | 4.846 | 37.815 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - House Med Hodor S.r.l.